Invention Grant
- Patent Title: Norovirus fusion proteins and VLPS comprising norovirus fusion proteins
-
Application No.: US16496244Application Date: 2018-03-23
-
Publication No.: US11608361B2Publication Date: 2023-03-21
- Inventor: Pierre-Olivier Lavoie , Marc-Andre D'Aoust
- Applicant: MEDICAGO INC.
- Applicant Address: CA Quebec
- Assignee: MEDICAGO INC.
- Current Assignee: MEDICAGO INC.
- Current Assignee Address: CA Quebec
- Agency: Sughrue Mion, PLLC
- International Application: PCT/CA2018/050352 WO 20180323
- International Announcement: WO2018/170603 WO 20180927
- Main IPC: C07K14/005
- IPC: C07K14/005 ; C12N7/00 ; C12N15/82 ; C07K16/10 ; A61K39/12 ; A61K9/00

Abstract:
Nucleic acids encoding norovirus VP1 fusion proteins and VLPs comprising the norovirus VP1 fusion proteins are provided. Methods for norovirus VP1 fusion protein and norovirus VLP production in plants are also described. The VP1 fusion protein comprises, a first sequence encoding an S domain derived from a first norovirus strain, and a second sequence encoding a P domain derived from a second norovirus strain.
Public/Granted literature
- US20200148725A1 NOROVIRUS FUSION PROTEINS AND VLPS COMPRISING NOROVIRUS FUSION PROTEINS Public/Granted day:2020-05-14
Information query